AI, Robotics, and the New Era of Pharma Production

Podcast Overview

In this episode of Navigating the Currents of Change, Shaheen Chohan is joined by Annette Kreuger, IIR’s Senior Vice President of Research for Pharma & Biotech, to explore how Pharmaceuticals and biotech remain two of the most active sectors for global capital investment heading into 2025. From explosive growth in GLP-1 weight-loss drug production to the expansion of biologics and cell & gene therapies, the project pipeline is strong, but not without challenges.

Presenters

Shaheen Chohan

Annette Kreuger

Video Language

Recent Podcast Episodes

All Industries

2026/27 Investment Radar for Mexico, Central America & the Caribbean

Uncover key 2026/27 investment trends in Mexico, Central America, and the Caribbean, balancing growth with regional challenges.

Watch Episode

Power

Innovations Shaping the Next Era of Power Generation

Discover how energy security may be outweighing sustainability as electricity demand surges. Learn about the challenges of balancing decarbonization with increasing base load requirements.

Watch Episode

Pharmaceuticals & Biotech

The Role of Contract Manufacturing in Global Pharma Growth

Discover how contract manufacturing, supply chain reshoring, and Pharma 4.0 innovations are transforming the pharmaceutical industry.

Watch Episode

All Industries

2026 North American Labor Outlook

Explore how reshoring initiatives, data center expansion, and modular construction techniques are reshaping the US industrial construction landscape, addressing labor shortages, and driving sustainable growth in capital projects.

Watch Episode

Discover our EnergyLive Dashboard and its tools, all powered by our data.

Explore Our EnergyLive Tools